Ebola Vaccine Undergoing First Real-World Test
Though the vaccine developed during the massive Ebola epidemic of 2014-2016 hasn’t yet been licensed, 7,500 doses have been sent to the Democratic Republic of Congo to prevent a new outbreak from spreading. So far, 46 infections have been reported and 26 have died. Health workers and those in contact with the infected will be the first treated with the rVSV-ZEBOV vaccine, which was found to be “highly protective” in a clinical trial. Vaccinations began Monday, and another 8,000 doses are on the way.